Background: Menopause occurs between the ages of 40 and 50, and marks the end of a woman's menstrual cycle. A period of time during which a woman does not have a monthly cycle for more than 12 months is known as post-menopause. Women may suffer challenges in their daily lives during this period, such as depression, anxiety, and sleep loss, all of which can have a negative impact on their quality of life. A decrease in hormone production, such as estrogen and progesterone, can cause menopause. To treat psychological difficulties in menopausal women, drugs such as vortioxetine and paroxetine, as well as selective serotonin reuptake inhibitors (SSRI) and anti-depressants, were advised. Objective: To evaluate the effects in women how menopause inducing depression, anxiety, quality of life and lack of sleep. Methodology: The recent studies related to the aim of the review were undertaken through a literature search to evaluate the effects in women how menopause inducing depression, anxiety, quality of life and lack of sleep. Conclusion: Menopause, post-menopause, and peri-menopause are age-related causes in women who are going through the menstrual cycle. There is no need for medication during this time, but in severe cases, medications such as selective serotonin reuptake inhibitors (SSRI) and antidepressants should be administered and also for vaginal dryness and irritation Ospemifene is suggested. Many more clinical researches on the benefits of menopausal compilations will be needed in the future. Keywords: Menopause, post- menopause, depression, estrogen, progesterone

Sleep apnea occurs when the upper airway repeatedly becomes blocked during sleep, reducing or entirely blocking airflow. This is referred to as obstructive sleep apnea. If the brain fails to provide the necessary impulses for breathing, the disease is known as central sleep apnea. Sleep apnea and other sleep breathing problems are a leading cause of medical, social, and occupational disability. Sleep apnea is also linked to pulmonary hypertension, cardiac arrhythmia and other neurocognitive effects, majority of individuals with sleep apnea go undetected, putting them at danger during surgery. It is critical to identify these patients so that relevant steps can be implemented as soon as possible. In this review article, we will discuss about sleep apnea issues and their possible causes. Keywords: Sleep apnea, Bradycardia, Tachycardia, Breathing, Hypercapnia

Background:The present study focuses upon studying the level of depression, anxiety and life satisfaction in acute and chronic schizophrenics. Schizophrenia is known to be a heterogeneous disorder characterized by positive symptoms, negative symptoms, disorganized state and cognitive deficits. Acute schizophrenia is a disorder consisting of various degrees of psychosis, characterized by the sudden onset of personality disorganization Methods: Thirty acute and thirty chronic schizophrenic patients were taken within the age range of 18 to 55 years of male sex only. A self developed socio-demographic and clinical data sheet was used to assess the socio-demographic correlates. The Beck Depression Inventory (BDI), the Hindi Version of Cattell's Self Analysis Form or IPAT Anxiety Scale Questionnaire (A.S.Q) and the Life Satisfaction Scale were used to assess the levels of depression, anxiety and life satisfaction respectively.Results: Significant differences were found between Acute and Chronic Schizophrenics in depression which was due to the four factors: Sense of Failure, Crying Spells, Social Withdrawal, and in Work Inhibition. No significant differences were found in anxiety (both covert and overt). On Life satisfaction, in the acute and chronic schizophrenia groups, the level of life satisfaction is more among the acute schizophrenia group in comparison to chronic schizophrenia group. Conclusion:The acute schizophrenia group appears to be having relatively higher level of depression than as compared to the chronic group. But at the same time the acute group seems to have better life satisfaction than the chronic schizophrenia group.